Covance to go it alone in China
This article was originally published in Scrip
Executive Summary
The international contract research organisation Covancehas decided not to pursue a planned Chinese joint venture with Wuxi PharmaTech. The US-based firm says it will now go it alone to build its business in what it sees as an attractive long-term market for outsourced services.